Last Updated:
Name Designation Appointment Date Status
Chundayil Suresh Krishnan

Appointed as Director since July 2009

Director 10-Jul-2009 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Anaitis Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Sujith Koloth

Appointed as Managing Director since April 2011

Managing Director 23-Apr-2011 Current
Chundayil Girish Krishnan

Appointed as Director since March 2011

Director 03-Mar-2011 Current

People Timeline

Explore the timeline of key personnel in Anaitis Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Door No. 15/189/7, 2Nd Floor, New Sujith Pharma Building, Jubili Road, Perintalmanna Kerala, 679322, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 679322
  • Country India
  • Website -
Frequently Asked Questions
You can contact Anaitis Pharmaceuticals Private Limited through their registered address at Door No. 15/189/7, 2Nd Floor, New Sujith Pharma Building, Jubili Road, Perintalmanna Kerala, 679322, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Anaitis Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • CHUNDAYIL SURESH KRISHNAN
  • SUJITH KOLOTH
  • CHUNDAYIL GIRISH KRISHNAN
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available